Chemoinformaics analysis of (Z)-Hex-3-enyl 3-phenylpropanoate
| Molecular Weight | 232.323 | nRot | 7 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 8 |
| Exact Molecular Weight | 232.146 | nRing | 1 |
| Solubility: LogS | -4.11 | nHRing | 0 |
| Solubility: LogP | 3.276 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.408 |
| Synth | 1.964 |
| Natural Product Likeliness | 0.677 |
| NR-PPAR-gamma | 0.06 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.022 |
| Pgp-sub | 0.003 |
| HIA | 0.008 |
| CACO-2 | -4.576 |
| MDCK | 0.0000538 |
| BBB | 0.95 |
| PPB | 0.94878 |
| VDSS | 1.086 |
| FU | 0.0373707 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.508 |
| CYP2c19-inh | 0.947 |
| CYP2c19-sub | 0.146 |
| CYP2c9-inh | 0.792 |
| CYP2c9-sub | 0.503 |
| CYP2d6-inh | 0.465 |
| CYP2d6-sub | 0.489 |
| CYP3a4-inh | 0.52 |
| CYP3a4-sub | 0.34 |
| CL | 10.577 |
| T12 | 0.916 |
| hERG | 0.294 |
| Ames | 0.061 |
| ROA | 0.122 |
| SkinSen | 0.945 |
| Carcinogencity | 0.401 |
| EI | 0.92 |
| Respiratory | 0.134 |
| NR-Aromatase | 0.023 |
| Antiviral | Yes |
| Prediction | 0.75017 |